在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

Human Nucleophosmin(NPM1) ELISA kit

  • 中文名稱(chēng):
    人核仁磷酸蛋白(NPM1)酶聯(lián)免疫試劑盒
  • 貨號(hào):
    CSB-EL015996HU
  • 規(guī)格:
    96T/48T
  • 價(jià)格:
    ¥3600/¥2500
  • 其他:

產(chǎn)品詳情

  • 產(chǎn)品描述:
    人核仁磷酸蛋白(NPM1)酶聯(lián)免疫試劑盒(CSB-EL015996HU)為雙抗夾心法ELISA試劑盒,定量檢測(cè)血清、血漿、組織勻漿、細(xì)胞裂解物樣本中的NPM1含量。NPM1是重要靶點(diǎn)。它在細(xì)胞生理過(guò)程中發(fā)揮關(guān)鍵作用,與核糖體合成、細(xì)胞周期調(diào)控等相關(guān)。研究發(fā)現(xiàn)其突變與急性髓系白血病發(fā)病緊密關(guān)聯(lián),相關(guān)機(jī)制研究多聚焦于其突變影響細(xì)胞內(nèi)信號(hào)通路等,有望為白血病治療提供新策略。試劑盒檢測(cè)范圍為23.5 pg/mL-1500 pg/mL,該產(chǎn)品適用于白血病發(fā)病機(jī)制研究、實(shí)體瘤中NPM1異常表達(dá)的分子機(jī)制探索、藥物干預(yù)效果評(píng)估等科研場(chǎng)景,例如通過(guò)血漿樣本分析體外模型中的蛋白動(dòng)態(tài)變化,或利用組織勻漿檢測(cè)動(dòng)物模型中NPM1的表達(dá)水平,亦可通過(guò)細(xì)胞裂解液評(píng)估基因編輯或藥物處理后細(xì)胞內(nèi)的蛋白表達(dá)差異。本品僅用于科研,不用于臨床診斷,產(chǎn)品具體參數(shù)及操作步驟詳見(jiàn)產(chǎn)品說(shuō)明書(shū)。
  • 別名:
    B23 ELISA Kit; MGC104254 ELISA Kit; NO38 ELISA Kit; NPM ELISA Kit; NPM_HUMAN ELISA Kit; NPM1 ELISA Kit; Nucleolar phosphoprotein B23 ELISA Kit; Nucleolar protein NO38 ELISA Kit; Nucleophosmin (nucleolar phosphoprotein B23 numatrin) ELISA Kit; Nucleophosmin ELISA Kit; nucleophosmin nucleoplasmin family member 1 ELISA Kit; Nucleophosmin/nucleoplasmin family member 1 ELISA Kit; Numatrin ELISA Kit; OTTHUMP00000161024 ELISA Kit; OTTHUMP00000161025 ELISA Kit; OTTHUMP00000223397 ELISA Kit; OTTHUMP00000223398 ELISA Kit
  • 縮寫(xiě):
  • Uniprot No.:
  • 種屬:
    Homo sapiens (Human)
  • 樣本類(lèi)型:
    serum, plasma, tissue homogenates, cell lysates
  • 檢測(cè)范圍:
    23.5 pg/mL-1500 pg/mL
  • 靈敏度:
    5.8 pg/mL
  • 反應(yīng)時(shí)間:
    1-5h
  • 樣本體積:
    50-100ul
  • 檢測(cè)波長(zhǎng):
    450 nm
  • 研究領(lǐng)域:
    Epigenetics and Nuclear Signaling
  • 測(cè)定原理:
    quantitative
  • 測(cè)定方法:
    Sandwich
  • 精密度:
    Intra-assay Precision (Precision within an assay): CV%<8%
    Three samples of known concentration were tested twenty times on one plate to assess.
    Inter-assay Precision (Precision between assays): CV%<10%
    Three samples of known concentration were tested in twenty assays to assess.
  • 線性度:
    To assess the linearity of the assay, samples were spiked with high concentrations of human NPM1 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
    SampleSerum(n=4)
    1:1Average %91
    Range %87-95
    1:2Average %96
    Range %90-102
    1:4Average %97
    Range %94-101
    1:8Average %95
    Range %90-98
  • 回收率:
    The recovery of human NPM1 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
    Sample TypeAverage % RecoveryRange
    Serum (n=5) 9087-96
    EDTA plasma (n=4)9793-103
  • 標(biāo)準(zhǔn)曲線:
    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
    pg/mlOD1OD2AverageCorrected
    15002.389 2.380 2.385 2.239
    7501.604 1.545 1.575 1.429
    3751.122 1.068 1.095 0.949
    187.50.721 0.733 0.727 0.581
    940.424 0.390 0.407 0.261
    470.303 0.301 0.302 0.156
    23.50.230 0.237 0.234 0.088
    00.141 0.150 0.146
  • 數(shù)據(jù)處理:
  • 貨期:
    3-5 working days

產(chǎn)品評(píng)價(jià)

靶點(diǎn)詳情

  • 功能:
    Involved in diverse cellular processes such as ribosome biogenesis, centrosome duplication, protein chaperoning, histone assembly, cell proliferation, and regulation of tumor suppressors p53/TP53 and ARF. Binds ribosome presumably to drive ribosome nuclear export. Associated with nucleolar ribonucleoprotein structures and bind single-stranded nucleic acids. Acts as a chaperonin for the core histones H3, H2B and H4. Stimulates APEX1 endonuclease activity on apurinic/apyrimidinic (AP) double-stranded DNA but inhibits APEX1 endonuclease activity on AP single-stranded RNA. May exert a control of APEX1 endonuclease activity within nucleoli devoted to repair AP on rDNA and the removal of oxidized rRNA molecules. In concert with BRCA2, regulates centrosome duplication. Regulates centriole duplication: phosphorylation by PLK2 is able to trigger centriole replication. Negatively regulates the activation of EIF2AK2/PKR and suppresses apoptosis through inhibition of EIF2AK2/PKR autophosphorylation. Antagonizes the inhibitory effect of ATF5 on cell proliferation and relieves ATF5-induced G2/M blockade. In complex with MYC enhances the transcription of MYC target genes.
  • 基因功能參考文獻(xiàn):
    1. NPM1 and SURF6 form heterotypic liquid-like droplets in the nucleolus. PMID: 29483575
    2. High NPM1 expression is associated with tongue neoplasms. PMID: 29746960
    3. his meta-analysis indicated that NPM may act as a valuable prognosis biomarker and a potential therapeutic target in human solid tumors. PMID: 30126359
    4. this paper shows that viral nucleocapsid interacts with NPM1 and protects it from proteolytic cleavage, enhancing Cell survival, and is involved in porcine epidemic diarrhea virus growth PMID: 28045037
    5. DNMT3A R882 mutation plays an important role in CN-AML patients' prognosis and clinical outcomes in the presence and absence of NPM1 and FLT3 mutations. PMID: 29079128
    6. Mutation in NPM1 gene is associated with Acute Myeloid Leukemia. PMID: 29530994
    7. Nucleoplasmic translocation of NPM1 is a prerequisite for stress-induced activation of p53. PMID: 27886181
    8. NPM1 gene B type mutation enhanced the proliferation and invasion of THP-1 AML cells through the regulation of TIMP-2, MMP-2, Ang-1, c-myc and CCND1 PMID: 29441887
    9. In this study, FLT3 and NPM1 mutations were evaluated in adult Iranian patients with de novo cytogenetically normal acute myeloid leukemia and its correlations with clinical and laboratory parameters were also assessed. PMID: 28294102
    10. These observations demonstrated that the expression and localization of NPM affected the homeostatic balance of oxidative stress in tumor cells via PRDX6 protein. The regulation axis of NPM/PRDX/ROS may provide a novel therapeutic target for cancer treatment. PMID: 28513872
    11. ese results enhance our understanding of the molecular mechanisms that govern nucleoli formation by demonstrating that PPM1D regulates nucleolar formation by regulating NPM phosphorylation status through a novel signalling pathway, PPM1D-CDC25C-CDK1-PLK1 PMID: 27619510
    12. Data suggest that the direct interaction of several regions of nucleophosmin 1 (NPM1) C-terminal domain (CTD) with cellular membranes could be implicated in diseases where NPM1 is mutated and/or where its overexpression is cytoxic. PMID: 29330024
    13. Mechanically, mutant NPM1 interacted with PML and mediated its delocalization as well as stabilization contributing to elevated autophagic activity and leukemic cell survival in vitro. PMID: 28740552
    14. Mutation analysis in NPM1 in acute myeloid leukemia. PMID: 27071442
    15. We conclude that the degradation of NPM1 and HEXIM1 through autophagy in certain AML subsets contributes to the activation of the BET pathway in these cells. PMID: 27732946
    16. miR-10b exerts its effects by repressing the translation of KLF4 and that NPM1-mA inhibits myeloid differentiation through the miR-10b/KLF4 axis. PMID: 27669739
    17. NPM1 may play an important role in tumor progress in salivary gland adenoid cystic carcinoma (SACC) and is a potential biomarker for SACC. PMID: 27501253
    18. Data show that phosphorylated forms of nucleophosmin 1 (NPM1) interact with androgen receptor (AR) in nucleoplasm. PMID: 26993766
    19. Studies indicate that nucleophosmin 1 (NPM1) has been considered as a promising target for the treatment of both haematologic and solid malignancies. PMID: 27058426
    20. Work identifies the TP53 tumor suppressor as a novel target through which NPM1-RARA impacts leukemogenesis. PMID: 26754533
    21. These results suggested that relocation of NPM altered its interactional network and consequently disturbed the primary functions, including cell proliferation, adhesion, migration, and invasion. NPM plays a promotional role in cancer. PMID: 28262969
    22. the consequence of mutations in NPM1 and possible mechanisms through which mutations lead to leukemogenesis (review0. PMID: 28111462
    23. NPM1 mutation but not RUNX1 mutation or multilineage dysplasia defines a prognostic subgroup within de novo acute myeloid leukemia lacking recurrent cytogenetic abnormalities PMID: 28370403
    24. Nucleophosmin 1 (NPM1) mutations in chronic myelomonocytic leukemia and their prognostic relevance. PMID: 28707414
    25. Multivariable analyses on time to relapse and OS revealed pre-transplant NPM1 MRD levels >1% as an independent prognostic factor for poor survival after allogeneic HSCT, whereas FLT3-ITD had no impact. Notably, outcome of patients with pre-transplant NPM1 MRD positivity >1% was as poor as that of patients transplanted with RD. PMID: 27471865
    26. Our results indicate that CD4 expression and older age are adverse prognostic factors in wild-type NPM1, FLT3-ITD-negative CN-AML. PMID: 28318150
    27. NPM1-dependent nucleolar PIDDosome is a key initiator of the caspase-2 activation cascade. PMID: 28432080
    28. Data indicate that NPM-ALK was distributed in equal amounts between the cytoplasm and the nucleus. PMID: 26657151
    29. The aim of this review is to look at the less well-described role of NPM1 in the DNA repair pathways as well as the role of NPM1 in the regulation of apoptosis and its mutation in cancers. [review] PMID: 27553022
    30. revealed that the localization of fluorescently labeled NPM is affected by the interaction between various forms of the protein PMID: 28384310
    31. value of mutated NPM1 in AML in risk assessment and evaluating prognosis PMID: 27416910
    32. NPM1 downregulation by P-STAT5 is mediated by impairing the BRCA1-BARD1 ubiquitin ligase, which controls the stability of NPM1. In turn, decreased NPM1 levels led to suppression of p53 expression, resulting in enhanced cell survival. PMID: 28005077
    33. These results suggest that the p38/NPM/PP2A complex acts as a dynamic sensor, allowing endothelial cells to react rapidly to acute oxidative stress. PMID: 27142525
    34. Nucleophosmin-anaplastic lymphoma kinase serves as the founding member of the ALK fusion protein family, and its role in malignant cell transformation is by far the best characterized and, thus, is the main focus of this review. [review] PMID: 27879258
    35. data suggest that NPM1 mutations are a secondary or late event in the pathogenesis of AML and are preceded by founder mutations in genes that may be associated with recently described preclinical states such as clonal hematopoiesis of indeterminate potential or clonal cytopenias of undetermined significance. PMID: 28152414
    36. Mutations of NPM1 gene is associated with Acute myeloid leukemia. PMID: 27636548
    37. RQ-PCR of the NPM1 type A mutation was more sensitive and reliable than MFC for determination of minimal residual disease , which might have clinical implications. PMID: 27191933
    38. The results demonstrated that NPM downregulation markedly reversed the effects of multidrug resistance in in human hepatoma cells. In addition, NPM downregulation reduced P-glycoprotein expression, as well as MDR1 expression. PMID: 28259962
    39. Only karyotype and mutated NPM1 (NPM1mut) were independent predictors of survival in acute myeloid leukemia PMID: 27643573
    40. Our study provides a method for systematic characterization of NPM1 oligomer formation changes and for screening inhibitors of NPM1 oligomerization. PMID: 27983985
    41. Mutation of NPM1 determined by the widely available and inexpensive Immunohistochemical(IHC )agrees closely with results of the standard molecular methods. Thus, technically and financially not well endowed laboratories can provide the prognostically and potentially therapeutically important information on NPM1 mutation using IHC. PMID: 27748301
    42. In pediatric patients with AML from Argentina, a favorable prognosis of AML with genotype NPM1-mutated/FLT3-ITD-negative was confirmed. PMID: 27436336
    43. This study investigated the expression level of miR-1, miR-486, and let-7a in 45 CN-AML patients well characterized for FLT3 and/or NPM1 mutations using real-time quantitative RT-PCR and evaluated the association between candidate miRs expression and clinical features PMID: 26526573
    44. data showed that the pre-transplant level of MRD in patients with normal karyotype AML harboring NPM1 mutation in CR provides important prognostic information, which as an independent prognostic factor predicts transplant results PMID: 27798920
    45. Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemia. PMID: 26471486
    46. In this study, a direct association was observed between NPMc(+)expression in AML, reduced antioxidant responses, and enhanced sensitivity to an oral proteasome inhibitor that induces oxidative stress. PMID: 26634271
    47. analysis of the frequency and features of Acute myeloid leukemia with mutated NPM1 in Indian patients PMID: 26669619
    48. Nucleophosmin Interacts with promyelocytic leukemia protein/retinoic acid receptor alpha Only in the Resistant Cell Line. PMID: 26997274
    49. Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse. PMID: 26642331
    50. results suggest that cup-like nuclei represent an important morphologic clue that can predict NPMc+ AML and guide toward prioritizing the further workup of AML patients PMID: 26200838

    顯示更多

    收起更多

  • 相關(guān)疾病:
    A chromosomal aberration involving NPM1 is found in a form of non-Hodgkin lymphoma. Translocation t(2;5)(p23;q35) with ALK. The resulting chimeric NPM1-ALK protein homodimerize and the kinase becomes constitutively activated.
  • 亞細(xì)胞定位:
    Nucleus, nucleolus. Nucleus, nucleoplasm. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Note=Generally nucleolar, but is translocated to the nucleoplasm in case of serum starvation or treatment with anticancer drugs. Has been found in the cytoplasm in patients with primary acute myelogenous leukemia (AML), but not with secondary AML. Can shuttle between cytoplasm and nucleus. Co- localizes with the methylated form of RPS10 in the granular component (GC) region of the nucleolus. Colocalized with nucleolin and APEX1 in nucleoli. Isoform 1 of NEK2 is required for its localization to the centrosome during mitosis.
  • 蛋白家族:
    Nucleoplasmin family
  • 數(shù)據(jù)庫(kù)鏈接:

    HGNC: 7910

    OMIM: 164040

    KEGG: hsa:4869

    STRING: 9606.ENSP00000296930

    UniGene: Hs.557550



主站蜘蛛池模板: 人妻无码一区二区三区av| 综合网日日天干夜夜久久| 日本japanese丰满白浆 | 亚洲人成无码网站18禁10| 久久只精品99品免费久23| 亚洲 小说 欧美 激情 另类 | 国产96在线 | 韩国| 九九99久久精品在免费线18| 亚洲精品鲁一鲁一区二区三区| 亚洲欧美乱日韩乱国产| 亚洲精品乱码久久久久久| 55夜色66夜色国产精品视频| 在线 | 国产精品星空传媒丿 | 国产欧美日韩中文久久| 亚洲www啪成人一区二区麻豆| 免费国产va在线观看| 蜜桃传媒av免费观看麻豆| 久久国产免费直播| 日本不卡高字幕在线2019| 精品国产久九九| 好爽...又高潮了毛片| 四虎影视在线影院在线观看免费视频| 国产爆乳无码一区二区麻豆 | 国产高清露脸孕妇系列 | 精品国产一区二区三区av性色 | 丰满熟妇人妻av无码区| 日本极品少妇xxxx| 久久久久欧美国产高潮| 无码人妻精品一区二区三区下载| 成人区人妻精品一区二区三区| 国产欧美久久一区二区三区| 亚洲中文字幕不卡无码| 成 人 网 站 免费观看| 国产精品自在线拍国产电影| 国产综合有码无码视频在线| 欧美视频网站www色| 青青草97国产精品免费观看| 成人爱做日本视频免费| 一区二区三区四区在线不卡高清| 欧美丰满老熟妇aaaa片| 在线播放无码后入内射少妇|